213 related articles for article (PubMed ID: 38108865)
1. [SARS-CoV-2 infection and autoimmunity].
Meyer-Bahlburg A
Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
[TBL] [Abstract][Full Text] [Related]
4. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation.
Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK
Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies.
Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K
Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 triggering autoimmune diseases.
Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and autoimmune diseases: is there a connection?
Votto M; Castagnoli R; Marseglia GL; Licari A; Brambilla I
Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):185-192. PubMed ID: 36728317
[TBL] [Abstract][Full Text] [Related]
9. The mosaic of autoimmunity - Finally discussing in person. The 13
Mahroum N; Elsalti A; Alwani A; Seida I; Alrais M; Seida R; Esirgun SN; Abali T; Kiyak Z; Zoubi M; Shoenfeld Y
Autoimmun Rev; 2022 Oct; 21(10):103166. PubMed ID: 35932955
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
Baiocchi GC; Vojdani A; Rosenberg AZ; Vojdani E; Halpert G; Ostrinski Y; Zyskind I; Filgueiras IS; Schimke LF; Marques AHC; Giil LM; Lavi YB; Silverberg JI; Zimmerman J; Hill DA; Thornton A; Kim M; De Vito R; Fonseca DLM; Plaça DR; Freire PP; Camara NOS; Calich VLG; Scheibenbogen C; Heidecke H; Lattin MT; Ochs HD; Riemekasten G; Amital H; Shoenfeld Y; Cabral-Marques O
J Med Virol; 2023 Feb; 95(2):e28538. PubMed ID: 36722456
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Vahabi M; Ghazanfari T; Sepehrnia S
Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
[TBL] [Abstract][Full Text] [Related]
13. Positive myositis-specific autoantibodies during COVID-19: a case report.
Abdelkrim AB; Ghozzi M; Saad G; Melayah S; Ach T; Ghedira I; Ach K
Pan Afr Med J; 2022; 43():181. PubMed ID: 36915412
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Systemic Sclerosis After Covid-19 Infection.
Fineschi S
Front Immunol; 2021; 12():686699. PubMed ID: 34262566
[TBL] [Abstract][Full Text] [Related]
15. The intersection of COVID-19 and autoimmunity.
Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: A trigger of autoimmune diseases.
Zebardast A; Hasanzadeh A; Ebrahimian Shiadeh SA; Tourani M; Yahyapour Y
Cell Biol Int; 2023 May; 47(5):848-858. PubMed ID: 36740221
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune complications of COVID-19.
Yazdanpanah N; Rezaei N
J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune liver diseases and SARS-CoV-2.
Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection and increasing autoimmune disorders among ICU-hospitalized COVID-19 patients.
Mosavat A; Mirhosseini A; Shariati A; Mohareri M; Valizadeh N; Mohammadi FS; Shamsian SAA; Jafari Rad M; Rezaee SA
Int J Rheum Dis; 2023 Nov; 26(11):2151-2156. PubMed ID: 37578135
[TBL] [Abstract][Full Text] [Related]
20. Overview of autoantibodies in COVID-19 convalescents.
Dobrowolska K; Zarębska-Michaluk D; Poniedziałek B; Jaroszewicz J; Flisiak R; Rzymski P
J Med Virol; 2023 Jun; 95(6):e28864. PubMed ID: 37310140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
